Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (101-110 of 258) with videos related to

Pageof 26
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2014
General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home careKarin Bergkvist, Jeanette Winterling, Eva Johansson, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
Pediatric Transplantation|June 3, 2016
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decadesPetter Svenberg, Mats Remberger, Mehmet Uzunel, et al.
Transplantation|March 25, 2009
Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantationMichael Uhlin, Mantas Okas, Helen Karlsson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized studyTapani Ruutu, Eeva Juvonen, Mats Remberger, et al.
Vox Sanguinis|August 13, 2019
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantationSofia Berglund, Emma Watz, Mats Remberger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationMats Remberger, Gunilla Kumlien, Johan Aschan, et al.
European Journal of Haematology|August 27, 2022
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groupsAlejandro Garcia-Horton, Sunu L Cyriac, Tobias Gedde-Dahl, et al.
Expert Review of Hematology|March 31, 2019
Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional statusTamas Agh, Marcell Csanadi, Zoltan Voko, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantationMantas Okas, Jens Gertow, Mehmet Uzunel, et al.
Pageof 26

Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2014
General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home careKarin Bergkvist, Jeanette Winterling, Eva Johansson, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
Pediatric Transplantation|June 3, 2016
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decadesPetter Svenberg, Mats Remberger, Mehmet Uzunel, et al.
Transplantation|March 25, 2009
Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantationMichael Uhlin, Mantas Okas, Helen Karlsson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized studyTapani Ruutu, Eeva Juvonen, Mats Remberger, et al.
Vox Sanguinis|August 13, 2019
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantationSofia Berglund, Emma Watz, Mats Remberger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationMats Remberger, Gunilla Kumlien, Johan Aschan, et al.
European Journal of Haematology|August 27, 2022
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groupsAlejandro Garcia-Horton, Sunu L Cyriac, Tobias Gedde-Dahl, et al.
Expert Review of Hematology|March 31, 2019
Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional statusTamas Agh, Marcell Csanadi, Zoltan Voko, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantationMantas Okas, Jens Gertow, Mehmet Uzunel, et al.
Pageof 26